Top Markets
#1 Cortex Cortex +173.61%
#2 GEKKO GEKKO +51.79%
#3 Audiera Audiera +19.71%
#4 ADO Protocol ADO Protocol +17.93%
#5 TENDIES TENDIES +15.98%
#6 Ontology Gas Ontology Gas +15.75%
#7 Pons Pons +15.23%
#8 Siren Siren +13.26%
#9 o1.exchange o1.exchange +13.03%
#10 Helium Helium +12.27%
Coin of the day
Cortex Cortex
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Longboard Pharmaceuticals, Inc. Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc.

LBPH
Classificação em ações #8563
Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm... Longboard Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm committed to advancing innovative treatments for neurological conditions. Its primary drug candidate, LP352, is currently progressing through a Phase 1b/2a clinical trial, aimed at managing seizures associated with developmental and epileptic encephalopathies. The company also boasts preclinical pipeline candidates, LP659 and LP143, designed to tackle a range of neurological diseases. Incorporated in 2020, the company, formerly known as Arena Neuroscience, Inc., adopted its current name, Longboard Pharmaceuticals, Inc., in October 2020. Its corporate headquarters are situated in La Jolla, California.
Preço da ação
$59.98
Última sincronização: 2024-12-13
Valor de mercado
$1.22B
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Longboard Pharmaceuticals, Inc. (LBPH)

Categoria

Healthcare
Receita da Longboard Pharmaceuticals, Inc. (LBPH)
Receita em Sep 2024 TTM: $8.00K
De acordo com os últimos relatórios financeiros da Longboard Pharmaceuticals, Inc., a receita atual da empresa (TTM) é $8.00K. Em 2022, a empresa obteve uma receita de 0.00 igual a a receita do ano 2021, que foi de 0.00. A receita é o valor total gerado pela venda de bens ou serviços. Ao contrário do lucro, nenhuma despesa é subtraída.
Histórico de receita da Longboard Pharmaceuticals, Inc. de 2020 a 2026
Receita no final de cada ano
Ano Receita Alterar
2026 (TTM) $8.00K 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
Receita de empresas similares ou concorrentes
Empresa Receita Diferença de Receita País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 157,803,650.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 75,265,991.36%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B 196,803,989.28%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B 27,849,900.00%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH